Skip to Main Content

Paper Details

Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.
Neuro Oncol
61
2019
Author NameAffiliation
Maria Martinez-LageMassachusetts General Hospital, Harvard Medical School
Maria Martinez-LageMassachusetts General Hospital, Harvard Medical School
Scott L CarterJoint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School
Priscilla K BrastianosCancer Center, Massachusetts General Hospital, Harvard Medical School
  • 1 - 4

Datasets

Release 1.2